Notice: This company has been marked as potentially delisted and may not be actively trading. NYSE:GEN Genesis Healthcare (GEN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrends About Genesis Healthcare Stock (NYSE:GEN) 30 days 90 days 365 days Advanced Chart Ad Chaikin AnalyticsIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is making headlines for last week's new earnings report – which revealed the AI juggernaut nearly doubled their profits in the last year alone.A 50-year Wall Street veteran gives his answer Nvidia, right here... Get Genesis Healthcare alerts:Sign Up Key Stats Today's Range$30.82▼$31.2050-Day Range$0.18▼$0.6052-Week Range$0.40▼$1.37Volume1.91 million shsAverage Volume4.10 million shsMarket Capitalization$19.72 billionP/E Ratio34.28Dividend Yield1.62%Price Target$30.20Consensus RatingHold Company OverviewGenesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.Read More… Is NVDA a sell? Buy this stock instead before Dec 3 (Ad)After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is making headlines for last week's new earnings report – which revealed the AI juggernaut nearly doubled their profits in the last year alone.A 50-year Wall Street veteran gives his answer Nvidia, right here... Genesis Healthcare Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks23rd Percentile Overall ScoreGEN MarketRank™: Genesis Healthcare scored higher than 23% of companies evaluated by MarketBeat, and ranked 275th out of 332 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingGenesis Healthcare has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageGenesis Healthcare has only been the subject of 2 research reports in the past 90 days.Read more about Genesis Healthcare's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth5.52% Earnings GrowthEarnings for Genesis Healthcare are expected to grow by 5.52% in the coming year, from $1.63 to $1.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Genesis Healthcare is 34.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 121.09.Price to Earnings Ratio vs. SectorThe P/E ratio of Genesis Healthcare is 34.28, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 29.89. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for GEN. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldGenesis Healthcare pays a meaningful dividend of 3.05%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthGenesis Healthcare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Genesis Healthcare is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Genesis Healthcare will have a dividend payout ratio of 29.07% next year. This indicates that Genesis Healthcare will be able to sustain or increase its dividend.Read more about Genesis Healthcare's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for GEN. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 3 news articles for Genesis Healthcare this week, compared to 5 articles on an average week.Search Interest8 people have searched for GEN on MarketBeat in the last 30 days. This is an increase of 60% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Genesis Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Genesis Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,476,708.00 in company stock.Percentage Held by InsidersOnly 3.30% of the stock of Genesis Healthcare is held by insiders.Percentage Held by Institutions82.08% of the stock of Genesis Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Genesis Healthcare's insider trading history. Receive GEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genesis Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address GEN Stock News HeadlinesGenesis crowns Pacific Smiles directors as major shareholder exitsNovember 29 at 10:34 PM | afr.comGEN Restaurant Group: Lots Of Potential Growth For PeanutsNovember 29 at 6:09 AM | seekingalpha.comCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.December 1, 2024 | Brownstone Research (Ad)Gen Digital: A Robust Business Facing A Secular ThreatNovember 22, 2024 | seekingalpha.comSouth Carolina Facility Recovers 39 Monkeys, 4 Still MissingNovember 21, 2024 | newsweek.comNorton Introduces Small Business Premium for Powerful, Easy-to-Use Business-Grade SecurityNovember 21, 2024 | prnewswire.comGen Q3 Threat Report: Millions Fooled by "Scam-Yourself Attacks"November 19, 2024 | prnewswire.comOnly 8 monkeys remain free after more than a week outside a South Carolina compoundNovember 14, 2024 | msn.comSee More Headlines GEN Stock Analysis - Frequently Asked Questions How were Genesis Healthcare's earnings last quarter? Genesis Healthcare, Inc. (NYSE:GEN) released its quarterly earnings results on Wednesday, October, 30th. The company reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by $0.01. The business had revenue of $975 million for the quarter, compared to the consensus estimate of $968.54 million. Genesis Healthcare had a net margin of 17.83% and a trailing twelve-month return on equity of 155.48%. Is Genesis Healthcare doing a stock buyback? Genesis Healthcare's Board of Directors initiated a share repurchase plan on Thursday, May 9th 2024, which permits the company to buy back $3,000,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 23.1% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's board of directors believes its shares are undervalued. Who are Genesis Healthcare's major shareholders? Genesis Healthcare's top institutional shareholders include FMR LLC (5.90%), State Street Corp (4.24%), Pacer Advisors Inc. (2.76%) and Geode Capital Management LLC (2.19%). Insiders that own company stock include Ondrej Vlcek and Bryan Seuk Ko. View institutional ownership trends. What other stocks do shareholders of Genesis Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genesis Healthcare investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE) and CrowdStrike (CRWD). Company Calendar Ex-Dividend for 9/11 Dividend8/19/2024Dividend Payable9/11/2024Last Earnings10/30/2024Ex-Dividend for 12/11 Dividend11/18/2024Today12/01/2024Dividend Payable12/11/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorBusiness Services Industry Prepackaged software Sub-IndustryN/A Current SymbolNYSE:GEN Previous SymbolNYSE:SKH CUSIPN/A CIK1351051 Webwww.genesishcc.com Phone610-444-6350Fax302-636-5454Employees2,700Year FoundedN/APrice Target and Rating Average Stock Price Target$30.20 High Stock Price Target$37.00 Low Stock Price Target$27.00 Potential Upside/Downside-2.1%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.90 Trailing P/E Ratio34.28 Forward P/E Ratio18.93 P/E GrowthN/ANet Income$836 million Net Margins17.83% Pretax Margin23.69% Return on Equity155.48% Return on Assets9.12% Debt Debt-to-Equity Ratio7.50 Current Ratio0.48 Quick Ratio0.48 Sales & Book Value Annual Sales$2.80 billion Price / Sales7.05 Cash Flow$3.66 per share Price / Cash Flow8.42 Book Value($0.16) per share Price / Book-192.81Miscellaneous Outstanding Shares639,130,000Free Float618,038,000Market Cap$19.72 billion OptionableOptionable Beta0.84 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report This page (NYSE:GEN) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored***TODAY ONLY*** Is this Trump’s Favorite Coin?Donald Trump just emphatically became America's first crypto president. Trump plans to make America, "the...Weiss Ratings | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genesis Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genesis Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
